BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2936098)

  • 1. Piriprost: a selective inhibitor of leukotriene synthesis.
    Bach MK; Bowman BJ; Brashler JR; Fitzpatrick FA; Griffin RL; Johnson HG; Major NJ; McGuire JC; McNee ML; Richards IM
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():225-7. PubMed ID: 2936098
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of the presumably leukotriene-dependent component of antigen-induced bronchoconstriction in the guinea pig by piriprost (U-60,257).
    Bach MK; Griffin RL; Richards IM
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):264-6. PubMed ID: 3924840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synthesis of 6,9-deepoxy-6,9-N-phenylimino-delta 6,8-prostaglandin I1. A novel inhibitor of leukotriene C and D synthesis.
    Smith HW; Bach MK; Harrison AW; Johnson HG; Major NJ; Wasserman MA
    Prostaglandins; 1982 Oct; 24(4):543-6. PubMed ID: 6817384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro actions of a new selective inhibitor of leukotriene C and D synthesis.
    Bach MK; Brashler JR; Fitzpatrick FA; Griffin RL; Iden SS; Johnson HG; McNee ML; McGuire JC; Smith HW; Smith RJ; Sun FF; Wasserman MA
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():39-44. PubMed ID: 6221551
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of human platelet and neutrophil function by piriprost (U-60,257).
    Mehta JL; Mehta P; Ward MB; Lawson D
    Prostaglandins Leukot Med; 1987 Oct; 29(2-3):259-67. PubMed ID: 3124134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of thyrotropin releasing hormone on the peripheral airway response induced by leukotriene D].
    Koshino T; Fujimura M; Nishioka S; Okafuji K; Minami S; Kanamori K; Matsuda T; Kitao T; Ishizaki T; Saga T
    Arerugi; 1984 Dec; 33(12):1059-62. PubMed ID: 6442855
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of rat liver glutathione S-transferases by piriprost: kinetics of the inhibition and preliminary evidence that piriprost may be a poor alternative substrate for these enzymes.
    Bach MK; O'Brien J; Brashler JR; Johnson MA; Morton DR
    Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):361-86. PubMed ID: 3903894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U-60,257 has no effect on the metabolism of arachidonic acid in nonstimulated human polymorphonuclear leukocytes.
    Dahl ML; Puustinen T; Uotila P
    Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):355-65. PubMed ID: 6431565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Piriprost, a 5-lipoxygenase inhibitor, on leukocyte accumulation during thioglycollate-induced acute inflammation.
    Lawson CF; Smith HW; Fitzpatrick FA
    Wien Klin Wochenschr; 1986 Feb; 98(4):110-3. PubMed ID: 3085355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Leukotrienes and inflammation].
    Borgeat P; Picard S; Poubelle P; Sirois P; Rola-Pleszczynski M; Braquet P
    Union Med Can; 1985 Aug; 114(8):611-7. PubMed ID: 2997964
    [No Abstract]   [Full Text] [Related]  

  • 11. 6,9-deepoxy-6,9,-(phenylimino)-delta 6,8-prostaglandin I1, (U-60,257), a new inhibitor of leukotriene C and D synthesis: in vitro studies.
    Bach MK; Brashler JR; Smith HW; Fitzpatrick FA; Sun FF; McGuire JC
    Prostaglandins; 1982 May; 23(5):759-71. PubMed ID: 6812165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological attempts to modulate leukotriene synthesis in aspirin-induced asthma.
    Nizankowska E; Sheridan AQ; Maile MH; Cross CJ; Czerniawska-Mysik G; Szcezklik A
    Agents Actions Suppl; 1987; 21():203-13. PubMed ID: 3314412
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of the eicosanoids: prostaglandins, prostacyclin, thromboxane and leukotrienes in the pathogenesis of bronchial asthma and other lung diseases].
    Karaulov AV; Silvestrov VP; Pomoĭnetskiĭ VD; Zakharov VN; Masenko VP
    Ter Arkh; 1986; 58(3):123-30. PubMed ID: 3520918
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of slow-reacting substance in asthma.
    Brocklehurst WE
    Adv Drug Res; 1970; 5():109-13. PubMed ID: 4923800
    [No Abstract]   [Full Text] [Related]  

  • 15. [Leukotrienes and the lung].
    Leitch AG
    Rev Mal Respir; 1984; 1(6):329-36. PubMed ID: 6099600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roflumilast inhibition of pulmonary leukotriene production and bronchoconstriction in ovalbumin-sensitized and -challenged Guinea pigs.
    Wollin L; Marx D; Wohlsen A; Beume R
    J Asthma; 2005 Dec; 42(10):873-8. PubMed ID: 16393727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic, gasometric and haematological effects of air infusion in dogs: leukotriene inhibition with U-60,257.
    Domb M; Goldstein J; Vincent JL; Azimi G; Lignian H; Bernard A; Brimioulle S; Lejeune P; Duchateau J
    Bull Eur Physiopathol Respir; 1986; 22(4):375-80. PubMed ID: 3094608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress of therapeutic agents for asthma--3) Trends in the development of leukotriene inhibitory agents].
    Ohata K; Kohno S
    Nihon Rinsho; 1987 Aug; 45(8):1843-52. PubMed ID: 2824881
    [No Abstract]   [Full Text] [Related]  

  • 19. Leukotriene synthesis inhibition increases pulmonary blood flow in fetal lambs.
    Heymann MA; LeBidois J; Soifer SJ; Clyman RI
    Chest; 1988 Mar; 93(3 Suppl):117S. PubMed ID: 3125017
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel arylthio- and arylsulfonylpropyloxyacetophenones: design and synthesis of L-648,051 and L-649,923, potent antagonists of leukotriene D4.
    Young RN; Jones TR; Atkinson JG; Bélanger P; Champion E; Denis D; DeHaven RN; Ford-Hutchinson AW; Fortin R; Frenette R
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():544-8. PubMed ID: 2959111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.